(C) Immunoprecipitation of the endogenous Squ from ovarian lysate revealed the interaction with Spn-E protein. Proteins were detected by western blotting analysis using the specific antibody for each ...

Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, United States This important study employed multiple orthogonal techniques and ...

Thermo Fisher (TMO) announced that its board of directors has authorized the repurchase of $4B of shares of its common stock in the open market ...

The drug of abuse testing market is projected to grow from USD 1.65 billion in 2023 to USD 2.69 billion by 2033, at a CAGR of ...

The global measurement technology in downstream processing market was valued at USD 5.0 billion in 2022 and is projected to ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

Thermo Fisher Scientific's board has approved a new $4 billion stock buyback program. The Waltham, Mass., Life-sciences giant on Friday said the new program has no expiration date and replaces its ...

Thermo Fisher Scientific Inc. (TMO) announced Friday that its Board of Directors has authorized the repurchase of $4 billion of ...

Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...